Elixirgen Therapeutics, Inc. funding

Elixirgen Therapeutics, Inc., a biotechnology company based in Baltimore, MD, filed a Form D with the SEC on November 13, 2025 and reported $4M raised.

Amount raised$4M

Offering size$4M

Filed with the SECNovember 13, 2025

First saleOctober 30, 2025

IndustryBiotechnology

SecuritiesDebt, Options or warrants, Security to be acquired on exercise

LocationBaltimore, MD

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far1

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Nov 13

Other health care rounds in Maryland

Kaigene, Inc.$55M · Oct 14Biotechnology Seraxis Holdings, Inc.$10M · Sep 24Biotechnology OS Therapies Inc$7.2M · Oct 23Biotechnology Templar Nova, Inc.$7M · Oct 7Biotechnology Accufy Diagnostics, Inc.$2M · Oct 28Biotechnology ColoWatch, Inc. /MD/$975K · Oct 8Other Health Care Drizzle Health, LLC$600K · Nov 10Biotechnology Terrace Systems, Inc.$250K · Sep 16Other Health Care